Meridian Bioscience reported $217.56M in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Abbott ABT:US $ 23429M 810M
Accelerate Diagnostics AXDX:US 61.11M 12.22M
Atrion ATRI:US 136.57M 2.8M
Becton, Dickinson and BDX:US $ 10152M 1845M
Bio Rad Laboratories BIO:US $ 3303.42M 1314.33M
Cerulean Pharma CERU:US $ 47.82M 7.48M
Cerus CERS:US $ 172.81M 14.29M
Meridian Bioscience VIVO:US $ 217.56M 13.91M
Myriad Genetics MYGN:US $ 427.4M 57.4M
Orasure Technologies OSUR:US $ 268.36M 20.07M
Quidel QDEL:US $ 2113.65M 673.34M
Sientra SIEN:US 134.94M 5.84M
Staar Surgical STAA:US $ 273.9M 2.49M
Thermo Fisher Scientific TMO:US $ 18776M 1337M
Utah Medical Products UTMD:US $ 75.85M 9.23M